Invention Grant
- Patent Title: Intravenous administration of tramadol
-
Application No.: US15612665Application Date: 2017-06-02
-
Publication No.: US09968551B2Publication Date: 2018-05-15
- Inventor: Lucy Lu , Scott Reines , Jeffrey Ping
- Applicant: Revogenex Ireland Ltd
- Applicant Address: IE Dublin
- Assignee: Revogenex Ireland Ltd
- Current Assignee: Revogenex Ireland Ltd
- Current Assignee Address: IE Dublin
- Agency: Davidson, Davidson & Kappel, LLC
- Main IPC: A61K31/135
- IPC: A61K31/135 ; A61K9/00

Abstract:
A method of treating pain, e.g., acute post-operative pain, by administering to a human patient(s) a therapeutically effective dose of tramadol intravenously in a dosing regimen which includes one or more loading doses administered at shortened intervals as compared to dosing at steady-state is disclosed. In preferred embodiments, the intravenous dosing regimen provides a Cmax and AUC of tramadol is similar to the Cmax and AUC of an oral dose of 100 mg tramadol HCl given every 6 hours. In certain preferred embodiments, the dosing regimen comprises 50 mg IV tramadol at Hour 0, followed by 50 mg at Hour 2, 50 mg at hour 4, and 50 mg every 4 hours thereafter (e.g., until the patient no longer requires treatment with tramadol).
Public/Granted literature
- US20170266108A1 INTRAVENOUS ADMINISTRATION OF TRAMADOL Public/Granted day:2017-09-21
Information query